Galectin Therapeutics Inc.

NASDAQ:GALT

Biotechnology

Healthcare
$2.91 +1.62%

+$0.05 today

Market cap
$191.64M
Beta
0.49
P/E (TTM)
-7.1
EPS (TTM)
-$0.40
52W Low $1.85High $7.13

Volume 0.26M

Average 0.32M

Private 5-step workspace

Build a GALT investment thesis

Turn Galectin Therapeutics Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.